Quantifying Glans Width Changes in Response to Preoperative Androgen Stimulation in Patients Undergoing Hypospadias Repair

Purpose: Testosterone (T) administration prior to hypospadias surgery to increase glans size remains controversial. Understanding T’s effect on glans width (GW) is essential to understanding its potential impact on surgical outcomes. We hypothesized that preoperative T in prepubertal boys significantly increases GW at the time of hypospadias surgery. Materials and Methods: Our single institutional database was queried to identify patients who underwent hypospadias surgery from 2016 to 2020, in which data for T administration and GW were available. Descriptive, nonparametric and categorical statistics were performed as indicated. Results: A total of 579 patients were eligible for analysis. Median age at surgery was 0.9 years (IQR 0.6–1.6). A total of 247/579 patients (42.7%) received T. The median GW at surgery was 15 mm (IQR 13–17). When comparing patients who had T administered to those who did not, we found a significant difference in GW at surgery (16 mm vs 14 mm, p <0.001). The median change in GW from the office to surgery was 4 mm for those receiving T vs 0 mm for those not receiving T (p <0.001). We identified a greater change in GW from preoperative to intraoperative measurements in patients who received 2 doses of T vs 1 dose (4 mm vs 2 mm, p <0.001). A histogram plot revealed the distribution of GW change at surgery. Conclusions: In our prospectively collected cohort of patients undergoing hypospadias surgery, we were able to quantitate the change in GW from preoperative T. Two doses of T resulted in a significant increase in GW vs 1 dose.

[1]  F. Farrokhyar,et al.  Evaluating the literature on preoperative androgen stimulation for hypospadias repair using the fragility index - can we trust observational studies? , 2021, Journal of pediatric urology.

[2]  M. Hiradfar,et al.  Pre-operative hormone stimulation in hypospadias repair: A facilitator or a confounder. , 2020, Journal of pediatric urology.

[3]  N. Kakkar,et al.  Outcome of urethroplasty after parenteral testosterone in children with distal hypospadias. , 2017, Journal of pediatric urology.

[4]  J. M. Netto,et al.  Biometry of the hypospadic penis after hormone therapy (testosterone and estrogen): A randomized, double-blind controlled trial. , 2016, Journal of pediatric urology.

[5]  E. Yerkes,et al.  Is glans penis width a risk factor for complications after hypospadias repair? , 2016, Journal of pediatric urology.

[6]  Arvind Krishnan,et al.  Preoperative Testosterone Therapy Prior to Surgical Correction of Hypospadias: A Review of the Literature , 2016, Cureus.

[7]  W. Snodgrass,et al.  Glans size is an independent risk factor for urethroplasty complications after hypospadias repair. , 2015, Journal of pediatric urology.

[8]  M. Safarinejad,et al.  The effect of parenteral testosterone administration prior to hypospadias surgery: A prospective, randomized and controlled study. , 2015, Journal of pediatric urology.

[9]  L. Braga,et al.  The Influence of Pre-Operative Hormonal Stimulation on Hypospadias Repair , 2015, Front. Pediatr..

[10]  Matthew I. Bury,et al.  Androgen supplementation in rats increases the inflammatory response and prolongs urethral healing. , 2015, Urology.

[11]  W. Snodgrass,et al.  Glans penis width in patients with hypospadias compared to healthy controls. , 2013, Journal of pediatric urology.

[12]  T. Hasegawa,et al.  The effect of intramuscular testosterone enanthate treatment on stretched penile length in prepubertal boys with hypospadias. , 2010, Urology.

[13]  G. Bartsch,et al.  The efficacy of dihydrotestosterone transdermal gel before primary hypospadias surgery: a prospective, controlled, randomized study. , 2008, The Journal of urology.

[14]  M. Reddy,et al.  Comparison of topical versus parenteral testosterone in children with microphallic hypospadias , 2008, Pediatric Surgery International.

[15]  L. Baskin,et al.  Hypospadias: anatomy, etiology, and technique. , 2006, Journal of pediatric surgery.

[16]  T. Ogata,et al.  Testosterone enanthate therapy is effective and independent of SRD5A2 and AR gene polymorphisms in boys with micropenis. , 2004, The Journal of urology.

[17]  C. Luo,et al.  Use of parenteral testosterone prior to hypospadias surgery , 2003, Pediatric Surgery International.

[18]  P. Donahoe,et al.  Ambiguous genitalia. , 1994, Current therapy in endocrinology and metabolism.

[19]  J. Gearhart,et al.  The use of parenteral testosterone therapy in genital reconstructive surgery. , 1987, The Journal of urology.